Treatment of anxiety by homoeopathy

Efficacy of individualized homoeopathic medicines in the treatment of Generalized Anxiety Disorder using Kentâ??s repertory: A double-blind, randomized, placebo-controlled clinical trial

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/03/012685

Enrollment

Registered

2018-03-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F411- Generalized anxiety disorder

Interventions

Intervention1: Individualized homoeopathic medicines in centesimal potencies: In centesimal potencies, each dose shall consist of 4 cane sugar globules no. 30 medicated with the indicated medicine, pr

indistinguishable from verum. To be taken thrice a day orally on clean tongue in empty stomach. Duration of therapy: 3 months

Eligibility

Inclusion criteria

Inclusion criteria: 1. Cases suffering from GAD, diagnosed as per DSM-V criteria 2. Moderate to severe cases of anxiety (GAD-7 scores 10-15 and HAM-A scores 18-30) 3. Both male and female patients 4. Age between 18 and 65 years 5. Patients giving written consent to participate in the study 7. Literate patients who can read Bengali and/or English

Exclusion criteria

Exclusion criteria: 1. Mild (GAD-7 15 and HAM-A > 30) cases of anxiety 2. Use of psychoactive medications prior to study entry that precluded participation included depot neuroleptics within 6 months; any neuroleptic, antidepressant, or anxiolytic within 2 weeks (5 weeks for fluoxetine); daily benzodiazepine therapy within 1 month; and concomitant treatment with any psychotropic drug (except zolpidem for sleep) or any drug with a psychotropic component. 3. Patients with other psychiatric diseases. 4. Cases suffering from uncontrolled systemic illness or life-threatening infections 5. Cases already undergoing homoeopathic treatment for any chronic disease 6. Substance abuse and/or dependence 7. Pregnant women, lactating mothers, and women who are planning pregnancy

Design outcomes

Primary

Measure	Time frame
Generalized Anxiety Disorder 7 (GAD-7) questionnaire (Bengali version)Timepoint: Baseline and after 3 months	—

Secondary

Measure	Time frame
Hamilton Anxiety Rating Scale (HAM-A)Timepoint: Baseline and after 3 months	—

Countries

India

Contacts

Public ContactAvijit Shee Burman

National Institute of Homoeopathy, Ministry of AYUSH, Govt. of India

asheeburman@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026